Determining the Standard of Review for Claim Construction: Supreme Court Holds Oral Argument for Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.

By Austen Paulsen for the Center for Law & Biomedical Sciences blog. The issue in this case is whether the Federal Circuit may set aside findings of fact made by a district court and review its claim construction de novo or if the Federal Circuit is required to grant deference to the district court’s factual findings as […]